DIAGNOSIS OF LYMPH NODE INVOLVEMENT IN RECTAL CANCER
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
N/A
Issued Date -
Dec 26, 2013
app pub date -
Apr 17, 2013
filing date -
Apr 17, 2012
priority date (Note) -
Abandoned
status (Latency Note)
Importance
Abstract
A method of determining the risk that a subject that has been diagnosed with rectal cancer has stage III rectal cancer is described. The method includes determining the expression levels of a plurality of differentially expressed genes in a rectal cancer sample from the subject, comparing the expression levels of the plurality of genes with the corresponding controls, and characterizing the subject as having an increased risk of having stage III rectal cancer if the expression levels of the genes are increased or decreased compared to the corresponding control values. The inventor has determined which genes are expressed at higher or lower levels by a subject who has stage III rectal cancer. Microarrays and kits for staging subjects are also provided.
First Claim
Family
International Classification(s)
Cited Art Landscape
Patent Citation Ranking
Advertisement
Advertisement
Advertisement
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully